31-Jan-18, Reuters
Singapore Medical Group and South Korea’s CHA Healthcare have together bought a majority stake in Australia's fourth-largest fertility clinic operator, City Fertility Centre.
Image: Reuters
Falling fertility rates across the region is spurring growth and deal-making in the in-vitro fertilisation (IVF) industry.
"A growing number of delayed pregnancies among women (and) rising awareness pertaining to infertility... are driving aggressive growth in the global IVF market," Singapore Medical Group Executive Director Beng Teck Liang said.